Optiver Holding
OLMA icon

Optiver Holding’s Olema Pharmaceuticals OLMA Stock Holding History

Optiver Holding’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.93K Sell
331
-8
-2% -$178 ﹤0.01% 1427
2025
Q4 		$8.47K Buy
339
+103
+44% +$1.83K ﹤0.01% 1185
2025
Q3 		$2.31K Buy
+236
New +$1.42K ﹤0.01% 2332

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Optiver Holding's OLMA Position: Q1 2026 in Review

Optiver Holding reduced its Olema Pharmaceuticals (OLMA) stake by 2.4% in Q1 2026, selling an estimated $178 and leaving 331 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1427.

Optiver Holding first reported a position in OLMA in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.47K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Optiver Holding held 331 shares of Olema Pharmaceuticals worth $4.93K as of Q1 2026.
  • Optiver Holding sold 8 Olema Pharmaceuticals shares in Q1 2026, an estimated $178.
  • Olema Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1427 holding.
  • Optiver Holding first reported a position in Olema Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Olema Pharmaceuticals position peaked at $8.47K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.